ArticleCancers2024

Cost-Utility Analysis of Tenofovir Alafenamide and Entecavir in Chronic Hepatitis B Patients: A Markov Decision Model.

Chun-Huang Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.